Cargando…

Therapeutic Instruments Targeting Meibomian Gland Dysfunction

The most prevalent type of meibomian gland dysfunction (MGD), which is obstructive, is the main cause of evaporative dry eye and is characterized by changes in the meibum composition and duct obstruction. Eyelid hygiene has usually been the most common clinical approach. However, alternative therapi...

Descripción completa

Detalles Bibliográficos
Autores principales: Valencia-Nieto, Laura, Novo-Diez, Andrea, Blanco-Vázquez, Marta, López-Miguel, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708534/
https://www.ncbi.nlm.nih.gov/pubmed/32968960
http://dx.doi.org/10.1007/s40123-020-00304-3
_version_ 1783617562430406656
author Valencia-Nieto, Laura
Novo-Diez, Andrea
Blanco-Vázquez, Marta
López-Miguel, Alberto
author_facet Valencia-Nieto, Laura
Novo-Diez, Andrea
Blanco-Vázquez, Marta
López-Miguel, Alberto
author_sort Valencia-Nieto, Laura
collection PubMed
description The most prevalent type of meibomian gland dysfunction (MGD), which is obstructive, is the main cause of evaporative dry eye and is characterized by changes in the meibum composition and duct obstruction. Eyelid hygiene has usually been the most common clinical approach. However, alternative therapies for MGD are emerging on the market. Some warming and humidity devices have led to an improvement in the signs and symptoms in MGD patients. Likewise, eyelid massaging and cleaning devices are also beneficial for ocular signs and symptoms; however, patients usually need more than one session to maintain the therapeutic effect. Thermal pulsation has been reported to be more efficient than other strategies, and the effects can last up to 12 months. Moreover, intense pulsed light therapy has been demonstrated to improve ocular signs and symptoms alone and in combination with other therapies. Proper counseling of clinicians considering MGD status and patient compliance will help patients to undergo the adequate technique that best suits their condition.
format Online
Article
Text
id pubmed-7708534
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-77085342020-12-03 Therapeutic Instruments Targeting Meibomian Gland Dysfunction Valencia-Nieto, Laura Novo-Diez, Andrea Blanco-Vázquez, Marta López-Miguel, Alberto Ophthalmol Ther Review The most prevalent type of meibomian gland dysfunction (MGD), which is obstructive, is the main cause of evaporative dry eye and is characterized by changes in the meibum composition and duct obstruction. Eyelid hygiene has usually been the most common clinical approach. However, alternative therapies for MGD are emerging on the market. Some warming and humidity devices have led to an improvement in the signs and symptoms in MGD patients. Likewise, eyelid massaging and cleaning devices are also beneficial for ocular signs and symptoms; however, patients usually need more than one session to maintain the therapeutic effect. Thermal pulsation has been reported to be more efficient than other strategies, and the effects can last up to 12 months. Moreover, intense pulsed light therapy has been demonstrated to improve ocular signs and symptoms alone and in combination with other therapies. Proper counseling of clinicians considering MGD status and patient compliance will help patients to undergo the adequate technique that best suits their condition. Springer Healthcare 2020-09-24 2020-12 /pmc/articles/PMC7708534/ /pubmed/32968960 http://dx.doi.org/10.1007/s40123-020-00304-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Review
Valencia-Nieto, Laura
Novo-Diez, Andrea
Blanco-Vázquez, Marta
López-Miguel, Alberto
Therapeutic Instruments Targeting Meibomian Gland Dysfunction
title Therapeutic Instruments Targeting Meibomian Gland Dysfunction
title_full Therapeutic Instruments Targeting Meibomian Gland Dysfunction
title_fullStr Therapeutic Instruments Targeting Meibomian Gland Dysfunction
title_full_unstemmed Therapeutic Instruments Targeting Meibomian Gland Dysfunction
title_short Therapeutic Instruments Targeting Meibomian Gland Dysfunction
title_sort therapeutic instruments targeting meibomian gland dysfunction
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708534/
https://www.ncbi.nlm.nih.gov/pubmed/32968960
http://dx.doi.org/10.1007/s40123-020-00304-3
work_keys_str_mv AT valencianietolaura therapeuticinstrumentstargetingmeibomianglanddysfunction
AT novodiezandrea therapeuticinstrumentstargetingmeibomianglanddysfunction
AT blancovazquezmarta therapeuticinstrumentstargetingmeibomianglanddysfunction
AT lopezmiguelalberto therapeuticinstrumentstargetingmeibomianglanddysfunction